Invests in
Stages:
Sectors:
Locations:
Min Investment:
$15,000,000.00Max Investment:
$50,000,000.00Target Investment:
$25,000,000.00
Lists including Hyun
Work Experience
2022
Vice President
2022
Healthcare growth equity fund focused on medical products, devices, diagnostics, consumer health, healthcare services, and healthcare IT
2017 - 2022
Senior Associate
2017 - 2022
Special situations investing in commercial or near commercial biopharma companies or products; involved in 7 deals with cumulative deal value >$1B. Notable deals include Shingrix (GSK), Zolgensma (Novartis), and Krystexxa (Horizon Therapeutics).
2016 - 2017
Investment Banking Analyst
2016 - 2017
Biopharma investment banking, advising on M&A, licensing deals, and capital raises for emerging biotech companies. Notable deals include Intellia Therapeutics (NTLA), Beigene (BGNE), Vericel (VCEL), and Dermira (DERM).
2015 - 2015
Finance Accounting Intern
2015 - 2015
Part-time FP&A role within Invivo Corporation, a subsidiary of Philips Healthcare that focuses on manufacturing MRI coils
2015 - 2015
Sales Representative
2015 - 2015
Part-time door-to-door lab equipment sales at the University of Florida campus
2013 - 2014
Intern
2013 - 2014
Intern at HealthQuest
2014 - 2014
FMP Analyst Intern
2014 - 2014
Intern in the Healthcare Financial Services division, which focused on lending to healthcare real estate entities (e.g. SNFs, NFs, and ALFs)